Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Sleep Disorders

  Free Subscription


Articles published in Chest

Retrieve available abstracts of 75 articles:
HTML format



Single Articles


    June 2026
  1. PENZ ED, Ip-Buting A, Tsai WH, Santana MJ, et al
    Twelve-Month Follow-Up and Economic Evaluation of an Alternative Care Provider Clinic for Severe Sleep-Disordered Breathing.
    Chest. 2026;169:1703-1716.
    PubMed     Abstract available


    May 2026
  2. SCHWARTZ AR, Jacobowitz O, Mickelson SA, Miller MB, et al
    Three-Year Outcomes of Proximal Hypoglossal Nerve Stimulation in OSA.
    Chest. 2026;169:1357-1370.
    PubMed     Abstract available


  3. STRASSBERGER C, Hedner J, Sands SA, Zou D, et al
    From Pulse to Phenotype: Sleep Apnea Endotyping for Polygraphy via Oximeter-Derived Autonomic Arousal.
    Chest. 2026;169:1345-1356.
    PubMed     Abstract available


    April 2026
  4. MOURAUX S, Lechartier B, Imler T, von Garnier C, et al
    Association Between Exertional Dyspnea and OSA.
    Chest. 2026;169:1091-1100.
    PubMed     Abstract available


    March 2026
  5. DOWMAN L, Landry S, Smallwood N, Moor C, et al
    International Stakeholder Engagement on Clinical Care and Research for Sleep Assessment and Nocturnal Hypoxemia in Pulmonary Fibrosis.
    Chest. 2026;169:676-686.
    PubMed     Abstract available


  6. DUNIETZ GL, Chervin RD, Tauman R, Shaklai S, et al
    OSA in Women: Associations With Reproductive Aging and Screening Challenges.
    Chest. 2026;169:803-812.
    PubMed     Abstract available


    February 2026
  7. SRIKAJON J, Tripipitsiriwat A, Orr JE
    A 62-Year-Old-Man With Severe Daytime Sleepiness After Primary Central Nervous System Lymphoma.
    Chest. 2026;169:e55-e60.
    PubMed     Abstract available


  8. PERGER E, Parati G, Faini A, Gell L, et al
    Acetazolamide Plus Atomoxetine for Obesity Hypoventilation Syndrome Treatment.
    Chest. 2026;169:527-537.
    PubMed     Abstract available


    January 2026
  9. KAW R, Shekhar S, Mehra R, Aboussouan L, et al
    The Influence of Heart Failure and Ventilatory Support mode on hospital morbidity and mortality in patients with or at risk for Obesity Hypoventilation syndrome: findings from the National Inpatient Sample.
    Chest. 2026 Jan 7:S0012-3692(25)05821-0. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available


  10. KAREGE G, Egger B, Lawi D, Bergeron A, et al
    How Using Different Oximeters May Affect Clinical Decision-Making: A Method Comparison Study in Patients Receiving CPAP or Noninvasive Ventilation.
    Chest. 2026;169:244-256.
    PubMed     Abstract available


  11. OSMAN AM, Carney AS, Ooi EH, Joshi H, et al
    Effect of Novel Hypoglossal Stimulation on Airflow and Airway Collapsibility in OSA.
    Chest. 2026;169:257-268.
    PubMed     Abstract available


    November 2025
  12. BEINART D, Williams ZJ, Cenerini G, Orton CM, et al
    A 17-Year-Old Male With Exertional Dyspnea and Somnolence.
    Chest. 2025;168:e149-e152.
    PubMed     Abstract available


    October 2025
  13. STEWART GM, Tong BK, deChazal P, Flood J, et al
    Relationship between Framingham 10-year cardiovascular disease risk score and pulse wave amplitude drop characteristics in a sleep clinic cohort.
    Chest. 2025 Oct 15:S0012-3692(25)05534-5. doi: 10.1016/j.chest.2025.
    PubMed     Abstract available


  14. WICKWIRE EM, Capaldi VF 2nd, Herrin J, Stryckman B, et al
    Health and Utilization Burden of OSA Among US Active-Duty Military Personnel.
    Chest. 2025;168:1023-1033.
    PubMed     Abstract available


    September 2025
  15. WU JY, Chen CC, Ling Tu W, Hsu WH, et al
    Clinical Impact of Tirzepatide on Patients With OSA and Obesity.
    Chest. 2025;168:785-796.
    PubMed     Abstract available


    August 2025
  16. PEKER Y, Celik Y, Zinchuk A, Sands SA, et al
    Hypoxic Burden is Associated with Cardiovascular Events: A Risk Stratification Analysis of the RICCADSA Cohort.
    Chest. 2025 Aug 14:S0012-3692(25)05023-8. doi: 10.1016/j.chest.2025.07.4081.
    PubMed     Abstract available


  17. GAYNOR-SODEIFI K, Eschbach E, Rapoport DM, Kundel V, et al
    A 67-Year-Old Woman With Unexplained Nocturnal Hypoxemia.
    Chest. 2025;168:e39-e43.
    PubMed     Abstract available


  18. TAN BKJ, Gao EY, Tan NKW, Yeo BSY, et al
    Machine Listening for OSA Diagnosis: A Bayesian Meta-Analysis.
    Chest. 2025;168:520-530.
    PubMed     Abstract available


    July 2025
  19. MESSINEO L, Preuss M, Azarbarzin A, Vena D, et al
    Effects of the Combination of Pimavanserin and Atomoxetine on OSA Severity: A Randomized Crossover Trial.
    Chest. 2025;168:223-235.
    PubMed     Abstract available


    April 2025
  20. TAMISIER R, Philippe C, Prigent A, Charley-Monaca C, et al
    Change in Sleep Quality Associated With Adaptive Servoventilation for Central Sleep Apnea: Six-Month Follow-Up of the Multicenter Nationwide French "Etude de Cohorte Observationnelle Multicentrique Francaise de Patients Ayant un Syndrome d'Apnees du S
    Chest. 2025;167:1204-1217.
    PubMed     Abstract available


  21. HOZUMI H, Endo Y, Kono M, Hasegawa H, et al
    Hypnotics and Mortality in Idiopathic Pulmonary Fibrosis: Hospital and National Data-Based Analysis.
    Chest. 2025;167:1107-1119.
    PubMed     Abstract available


    March 2025
  22. VAN DONGEN HPA, Leary EB, Drake C, Bogan R, et al
    Results of the Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-Controlled Study (SHARP): A Randomized Placebo-Controlled Double-Blind Repeated-Measures Crossover Phase IV Clinical Trial of the Effect of the
    Chest. 2025;167:863-875.
    PubMed     Abstract available


    February 2025
  23. XAVIER JLA, Fernandes MD, Andrade RGS, Genta PR, et al
    Impact of Exclusive Mouth Route and Lateral Position on the Efficacy of Oronasal CPAP to Treat OSA in Patients With OSA Adapted to Oronasal Mask.
    Chest. 2025;167:611-618.
    PubMed     Abstract available


    January 2025
  24. NOWALK NC, Mokhlesi B, Neborak JM, Masa Jimenez JF, et al
    Gender Differences in Outcomes of Ambulatory and Hospitalized Patients With Obesity Hypoventilation Syndrome.
    Chest. 2025;167:245-258.
    PubMed     Abstract available


    November 2024
  25. AZZOPARDI M, Parsons R, Cadby G, King S, et al
    Identifying Risk of Postoperative Cardiorespiratory Complications in OSA.
    Chest. 2024;166:1197-1208.
    PubMed     Abstract available


  26. AZARBARZIN A, Labarca G, Kwon Y, Wellman A, et al
    Physiologic Consequences of Upper Airway Obstruction in Sleep Apnea.
    Chest. 2024;166:1209-1217.
    PubMed     Abstract available


    October 2024
  27. PATEL SR
    Unraveling the Healthy Adherer Effect in the Clinical Management of Sleep Apnea With CPAP.
    Chest. 2024;166:671-672.
    PubMed    


  28. LAUNOIS C, Bailly S, Sabil A, Goupil F, et al
    Association Between Healthy Behaviors and Health Care Resource Use With Subsequent Positive Airway Pressure Therapy Adherence in OSA.
    Chest. 2024;166:845-856.
    PubMed     Abstract available


  29. DHARMAKULASEELAN L, Boulos MI
    Sleep Apnea and Stroke: A Narrative Review.
    Chest. 2024;166:857-866.
    PubMed     Abstract available


    September 2024
  30. PENDHARKAR SR, Kaambwa B, Kapur VK
    The Cost-Effectiveness of Sleep Apnea Management: A Critical Evaluation of the Impact of Therapy on Health Care Costs.
    Chest. 2024;166:612-621.
    PubMed     Abstract available


    August 2024
  31. HORVATH CM, Fisser C, Floras JS, Sossalla S, et al
    Nocturnal Cardiac Arrhythmias in Heart Failure with Obstructive and Central Sleep Apnea.
    Chest. 2024 Aug 19:S0012-3692(24)04913-4. doi: 10.1016/j.chest.2024.
    PubMed     Abstract available


    July 2024
  32. EDWARDS BA, Joosten SA, Sands SA
    A Detailed Mechanistic Understanding of Positional and Nonpositional OSA: What Side Are You On?
    Chest. 2024;166:7-9.
    PubMed    


  33. WANG X, Zhou T, Huang W, Zhang J, et al
    Differences in Physiologic Endotypes Between Nonpositional and Positional OSA: Results From the Shanghai Sleep Health Study Cohort.
    Chest. 2024;166:212-225.
    PubMed     Abstract available


    June 2024
  34. YU JL, Plageman JM, Gouldman KP, Bliwise DL, et al
    Effects of Negative Pressure Ventilation on Lung Volume and Airflow in Drug-Induced Sleep Endoscopy.
    Chest. 2024;165:1534-1537.
    PubMed    


    May 2024
  35. SHELGIKAR AV
    Sleep Education: A Narrative Review on Barriers and Opportunities to Grow a Diverse Sleep Team.
    Chest. 2024;165:1239-1246.
    PubMed     Abstract available


  36. ALPERT N, Cole KV, Dexter RB, Sterling KL, et al
    Performance of Claims-Based Algorithms for Adherence to Positive Airway Pressure Therapy in Commercially Insured Patients With OSA.
    Chest. 2024;165:1228-1238.
    PubMed     Abstract available


    April 2024
  37. QU XR, Han T, Li YM, Zhang XL, et al
    A 38-Year-Old Woman With REM Predominant Central Sleep Apnea After Bulbar Infarction.
    Chest. 2024;165:e101-e106.
    PubMed     Abstract available


  38. AYAPPA I, Tolbert TM, Rapoport DM
    Flow Limitation Frequency: A Metric to Assess Consequences of OSA?
    Chest. 2024;165:769-770.
    PubMed    


  39. STAYKOV E, Mann DL, Duce B, Kainulainen S, et al
    Increased Flow Limitation During Sleep Is Associated With Increased Psychomotor Vigilance Task Lapses in Individuals With Suspected OSA.
    Chest. 2024;165:990-1003.
    PubMed     Abstract available


  40. LUCIANO YM, Porcacchia AS, Tufik S, Andersen ML, et al
    Prevalence and Incidence of Co-Morbid Insomnia and Sleep Apnea (Comisa) in Sao Paulo, Brazil.
    Chest. 2024;165:1004-1008.
    PubMed    


  41. GRAZIANO S, Boldrini F, Pellicano GR, Milo F, et al
    Longitudinal Effects of Elexacaftor/Tezacaftor/Ivacaftor: Multidimensional Assessment of Neuropsychological Side Effects and Physical and Mental Health Outcomes in Adolescents and Adults.
    Chest. 2024;165:800-809.
    PubMed     Abstract available


    March 2024
  42. LABARCA G, Singh B
    Pitolisant: A Game Changer for Managing Sleepiness in OSA?
    Chest. 2024;165:486-487.
    PubMed    


  43. PEPIN JL, Attali V, Causse C, Verbraecken J, et al
    Long-Term Efficacy and Safety of Pitolisant for Residual Sleepiness Due to OSA.
    Chest. 2024;165:692-703.
    PubMed     Abstract available


  44. HOFF E, Strassberger C, Zou D, Grote L, et al
    Modification of Endotypic Traits in OSA by the Carbonic Anhydrase Inhibitor Sulthiame.
    Chest. 2024;165:704-715.
    PubMed     Abstract available


    February 2024
  45. STANSBURY R, Billings ME
    Interpersonal Racism Contribution to Sleep Health Disparities: The Case of CPAP Adherence.
    Chest. 2024;165:246-247.
    PubMed    


  46. WALLACE DM, Grant AB, Belisova-Gyure Z, Ebben M, et al
    Discrimination Predicts Suboptimal Adherence to CPAP Treatment and Mediates Black-White Differences in Use.
    Chest. 2024;165:437-445.
    PubMed     Abstract available


    January 2024
  47. PEIXOTO DE MIRANDA EJF, Mazzotti DR, Santos RB, Souza SP, et al
    Incident Coronary Calcium Score in Patients With OSA With and Without Excessive Sleepiness: Brazilian Longitudinal Study of Adult Health.
    Chest. 2024;165:202-212.
    PubMed     Abstract available


    December 2023
  48. GOMEZ-OLIVAS JD, Campos-Rodriguez F, Nagore E, Martorell A, et al
    Role of Sleep Apnea and Long-Term CPAP Treatment in the Prognosis of Patients With Melanoma: A Prospective Multicenter Study of 443 Patients.
    Chest. 2023;164:1551-1559.
    PubMed     Abstract available


    November 2023
  49. PENGO MF, Oscullo G, Gomez-Olivas JD, Bilo G, et al
    Nocturnal BP Profile Predicts CPAP Effect on BP in Patients With OSA and Resistant Hypertension.
    Chest. 2023;164:1302-1304.
    PubMed    


  50. MYALL KJ, West AG, Martinovic JL, Lam JL, et al
    Nocturnal Hypoxemia Associates With Symptom Progression and Mortality in Patients With Progressive Fibrotic Interstitial Lung Disease.
    Chest. 2023;164:1232-1242.
    PubMed     Abstract available


    October 2023
  51. MARRIOTT RJ, Singh B, McArdle N, Darcey E, et al
    Does OSA Increase Risk for Cancer?: A Large Historical Sleep Clinic Cohort Study.
    Chest. 2023;164:1042-1056.
    PubMed     Abstract available


  52. AURORA RN, Rooney MR, Wang D, Selvin E, et al
    Effects of Positive Airway Pressure Therapy on Glycemic Variability in Patients With Type 2 Diabetes and OSA: A Randomized Controlled Trial.
    Chest. 2023;164:1057-1067.
    PubMed     Abstract available


    September 2023
  53. LANDRY SA, Mann DL, Beare R, McIntyre R, et al
    Oronasal vs Nasal Masks: The Impact of Mask Type on CPAP Requirement, Pharyngeal Critical Closing Pressure (P(crit)), and Upper Airway Cross-Sectional Areas in Patients With OSA.
    Chest. 2023;164:747-756.
    PubMed     Abstract available


    August 2023
  54. JUN JC, Taylor SL
    Could Sleep Apnea Be Suffocating Your Gut Microbiome?
    Chest. 2023;164:290-291.
    PubMed    


  55. LIM DC, Keenan BT
    Polysomnographic Subtypes and Incident Cancer: Another Adverse Outcome Related to Period Limb Movements.
    Chest. 2023;164:287-289.
    PubMed    


  56. BALDANZI G, Sayols-Baixeras S, Theorell-Haglow J, Dekkers KF, et al
    OSA Is Associated With the Human Gut Microbiota Composition and Functional Potential in the Population-Based Swedish CardioPulmonary bioImage Study.
    Chest. 2023;164:503-516.
    PubMed     Abstract available


  57. KENDZERSKA T, Murray BJ, Gershon AS, Povitz M, et al
    Polysomnographic Assessment of Sleep Disturbances in Cancer Development: A Historical Multicenter Clinical Cohort Study.
    Chest. 2023;164:517-530.
    PubMed     Abstract available


    July 2023
  58. TURNBULL CD, Bailly S
    For One Night Only: Are Single-Night Studies Sufficient to Predict Risk of Hypertension in OSA?
    Chest. 2023;164:15-17.
    PubMed    


    June 2023
  59. ALEXOPOULOS EI, Kaditis AG
    Intranasal Corticosteroids for Childhood OSA Syndrome: The Jury Is Still Out.
    Chest. 2023;163:e292.
    PubMed    


  60. POWELL TA, Morris MJ, Holley A
    Does Untreated OSA Really Influence Exercise Tolerance?
    Chest. 2023;163:e288-e289.
    PubMed    


  61. ALBRECHT JS, Kapur VK
    Untangling Treatment Effect From Patient Factors: The Challenge of the Use of Observational Studies to Investigate the Impact of Positive Airway Pressure Therapy on Medical Costs.
    Chest. 2023;163:1358-1359.
    PubMed    


  62. KASI AS, Tapia IE
    Can Physiologic Biomarkers Predict Neurocognition in Congenital Central Hypoventilation Syndrome?
    Chest. 2023;163:1356-1357.
    PubMed    


  63. AN J, Glick HA, Sawyer AM, Arguelles J, et al
    Association Between Positive Airway Pressure Adherence and Health Care Costs Among Individuals With OSA.
    Chest. 2023;163:1543-1554.
    PubMed     Abstract available


  64. SLATTERY SM, Zelko FA, Vu EL, Dunne EC, et al
    Ventilatory and Orthostatic Challenges Reveal Biomarkers for Neurocognition in Children and Young Adults With Congenital Central Hypoventilation Syndrome.
    Chest. 2023;163:1555-1564.
    PubMed     Abstract available


    May 2023
  65. TURNBULL CD, Thomas RJ
    Seeking Precision: Endotypes and Phenotypes of OSA.
    Chest. 2023;163:1016-1017.
    PubMed    


  66. ROSSETTO A, Midelet A, Baillieul S, Tamisier R, et al
    Factors Associated With Residual Apnea-Hypopnea Index Variability During CPAP Treatment.
    Chest. 2023;163:1258-1265.
    PubMed     Abstract available


  67. STRASSBERGER C, Hedner J, Sands SA, Tolbert TM, et al
    Night-to-Night Variability of Polysomnography-Derived Physiologic Endotypic Traits in Patients With Moderate to Severe OSA.
    Chest. 2023;163:1266-1278.
    PubMed     Abstract available


  68. BOTTAZ-BOSSON G, Midelet A, Mendelson M, Borel JC, et al
    Remote Monitoring of Positive Airway Pressure Data: Challenges, Pitfalls, and Strategies to Consider for Optimal Data Science Applications.
    Chest. 2023;163:1279-1291.
    PubMed     Abstract available


    April 2023
  69. GENTA PR, Taranto-Montemurro L
    Task Accomplished: Promising Effects of a New Topical Potassium Channel Antagonist in OSA.
    Chest. 2023;163:749-750.
    PubMed    


  70. LUTSEY PL, Zineldin I, Misialek JR, Full KM, et al
    OSA and Subsequent Risk of Hospitalization With Pneumonia, Respiratory Infection, and Total Infection: The Atherosclerosis Risk in Communities Study.
    Chest. 2023;163:942-952.
    PubMed     Abstract available


  71. OSMAN AM, Mukherjee S, Altree TJ, Delbeck M, et al
    Topical Potassium Channel Blockage Improves Pharyngeal Collapsibility: A Translational, Placebo-Controlled Trial.
    Chest. 2023;163:953-965.
    PubMed     Abstract available


    March 2023
  72. RAJVANSHI N, Prabhakaran K, Kumar P, Goyal JP, et al
    A Trial of Intranasal Corticosteroids to Treat Childhood OSA Syndrome: Is It Ineffective?
    Chest. 2023;163:e149.
    PubMed    


  73. PUNJABI NM, Brown TT, Aurora RN, Patel SR, et al
    Prevalence and Predictors of Sleep-Disordered Breathing in Men Participating in the Multicenter AIDS Cohort Study.
    Chest. 2023;163:687-696.
    PubMed     Abstract available


    February 2023
  74. HAO W, Wang X, Fan J, Guo R, et al
    Prognostic Implications of Obstructive Sleep Apnea in Acute Coronary Syndrome by Obesity Status.
    Chest. 2023 Feb 8:S0012-3692(23)00173-3. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


    January 2023
  75. LECHAT B, Nguyen DP, Reynolds A, Loffler K, et al
    Single night diagnosis of sleep apnea contributes to inconsistent cardiovascular outcome findings.
    Chest. 2023 Jan 27:S0012-3692(23)00157-5. doi: 10.1016/j.chest.2023.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sleep Disorders is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum